Provider education

2 papers2 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

2 independent labs in 1 country

Human trial2

Outcomes

ADRD diagnosis and treatment

upin humans1+60%

1 study

Provider education increases ADRD diagnosis and treatment in humans (60%).
“The intervention provider group was small (n = 4) but they did increase diagnosis and treatment by 60%, while the control group (n = 10) rates were unchanged.”
Human trialin rural primary care providersn = 14
Learning What Not to Do in Community-Engaged Nursing Research in Rural Settings
GSA 2025 abstract31 Dec 2025

Lipid-lowering treatment

no changein humans1

1 study

Provider education has no effect on lipid-lowering treatment in humans (p = 0.13 for new meds; p = 0.60 for achieved goal).
“The educational intervention did not appear to impact these rates (Chi-square test, p = 0.13 for new meds; p = 0.60 for achieved goal).”
Human trialLDL-C > 190 mg/dln = 57,277
Impact of a Familial Hypercholesterolemia Education Initiative on Use of Lipid Lowering Treatment: the CARE-FH Study
AHA Scientific Sessions 2025 abstract3 Nov 2025